Lisinopril/HCTZ
- Product NDC
- 61919-523
- 11-digit product format
- 619190523
- Labeler code
- 61919
- Product ID
- 61919-523_ea4e7175-945f-6be8-e053-2a95a90a507c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril/HCTZ
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2019-08-07
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-523-30 | 61919052330 | 30 TABLET in 1 BOTTLE (61919-523-30) | 30 tablet | 2019-08-07 | 0000-00-00 | No | No | Current |
| 61919-523-90 | 61919052390 | 90 TABLET in 1 BOTTLE (61919-523-90) | 90 tablet | 2019-04-18 | 0000-00-00 | No | No | Current |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Lisinopril | Direct_Rx | 2022-10-05 | HUMAN PRESCRIPTION DRUG LABEL | 2 |
| Lisinopril | Direct_Rx | 2019-04-18 | HUMAN PRESCRIPTION DRUG LABEL | 2 |